"Two‐year outcomes of low‐exposure extended‐release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi‐center randomized controlled trial"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Two‐year outcomes of low‐exposure extended‐release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi‐center randomized controlled trial

Once‐daily extended‐release tacrolimus (TACER) is commonly administered following kidney transplantation (KTx); however, its optimal dosage remains unknown. Click to show full abstract

Once‐daily extended‐release tacrolimus (TACER) is commonly administered following kidney transplantation (KTx); however, its optimal dosage remains unknown.

Keywords: extended release; transplantation; kidney transplantation; release tacrolimus

Journal Title: Clinical Transplantation
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended